Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Current Leases (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Current Leases for 4 consecutive years, with $174000.0 as the latest value for Q4 2025.

  • Quarterly Current Leases rose 1640.0% to $174000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $174000.0 through Dec 2025, up 1640.0% year-over-year, with the annual reading at $174000.0 for FY2025, 1640.0% up from the prior year.
  • Current Leases for Q4 2025 was $174000.0 at Day One Biopharmaceuticals, up from $161000.0 in the prior quarter.
  • The five-year high for Current Leases was $462000.0 in Q3 2022, with the low at $10000.0 in Q4 2024.
  • Average Current Leases over 4 years is $267625.0, with a median of $245000.0 recorded in 2024.
  • The sharpest move saw Current Leases plummeted 97.55% in 2024, then skyrocketed 1640.0% in 2025.
  • Over 4 years, Current Leases stood at $405000.0 in 2022, then rose by 0.74% to $408000.0 in 2023, then tumbled by 97.55% to $10000.0 in 2024, then surged by 1640.0% to $174000.0 in 2025.
  • According to Business Quant data, Current Leases over the past three periods came in at $174000.0, $161000.0, and $153000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.